Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Equity Residential To Sell 27 Properties For $1.5 Bln

RELATED NEWS
Trade EQR now with 

Equity Residential (EQR: Quote) Monday said it has agreed to sell 27 properties to a joint venture of Goldman, Sachs & Co. (GS) and Greystar Real Estate Partners LLC for $1.5 billion.

The transaction values the 27 properties at about $187,000 per apartment unit. Equity Residential has granted the buyer the right to exclude up to 8 percent of the assets from their purchase, but are obligated to purchase not less than $1.38 billion of assets.

David Neithercut, Equity Residential's chief executive officer, "With this transaction we will have made significant progress selling assets in our exit markets and non-core assets in primary markets to fund our share of the acquisition of Archstone."

The joint venture has agreed to buy a total of 8,010 units located at Washington, northern New Jersey, Florida, Phoenix, Denver, southern California and San Francisco bay areas.

Last November, Equity Residential had agreed to buy 60 percent of apartment owner Archstone Enterprise LP from Lehman Brothers Holdings Inc. in a cash and stock deal worth $6.5 billion. AvalonBay Communities, Inc. (AVB) is acquiring the rest 40 percent.

Equity Residential had said it would fund a substantial portion of the acquisition with proceeds from asset sales.

EQR is currently trading at $57.36, up $0.13 or 0.23%, on the NYSE.

Register
To receive FREE breaking news email alerts for Equity Residential and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.